ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,33 € ↑0,20 (3,26%)
2026-06-04
AKTIENPREIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership61,592 shares
Latest Disclosed Value $ 472,411
Captrust Financial Advisors reports 9.21% increase in ownership of 26CA / ImmunityBio, Inc.

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 61,592 shares of ImmunityBio, Inc. (DE:26CA) valued at $404,044 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 56,397 shares of ImmunityBio, Inc.. This represents a change in shares of 9.21% during the quarter. The current value of the position is $389,877 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F IMMUNITYBIO INC COM Stock 45256X103 61,592 5,195 9.21 472 325.23 0.0008
2026-02-17 2025-12-31 13F IMMUNITYBIO INC COM Stock 45256X103 56,397 249 0.44 112 -19.57 0.0002
2025-11-19 2025-09-30 13F IMMUNITYBIO INC COM Stock 45256X103 56,148 42,762 319.45 138 294.29 0.0003
2025-08-15 2025-06-30 13F IMMUNITYBIO INC COM Stock 45256X103 13,386 2,645 24.63 35 9.38 0.0001
2025-05-15 2025-03-31 13F IMMUNITYBIO INC COM Stock 45256X103 10,741 10,741 32 0.0001
2025-02-14 2024-12-31 13F IMMUNITYBIO INC COM Stock 45256X103 0 -11,073 -100.00 0 -100.00
2024-11-14 2024-09-30 13F IMMUNITYBIO INC COM Stock 45256X103 11,073 11,073 41 0.0001
2022-11-16 2022-09-30 13F IMMUNITYBIO INC COM Common Stock 45256X103 0 -1,920 -100.00 0 -100.00
2022-08-23 2022-06-30 13F/A-1 IMMUNITYBIO INC COM Common Stock 45256X103 1,920 0 0.00 7 -36.36 0.0000
2022-08-16 2022-06-30 13F IMMUNITYBIO INC COM COM 45256X103 1,920 0 7 0.0001
2022-05-16 2022-03-31 13F IMMUNITYBIO COM 45256X103 1,920 0 0.00 11 -8.33 0.0001
2022-02-14 2021-12-31 13F IMMUNITYBIO INC COM Common Stock 45256X103 1,920 0 0.00 12 -36.84 0.0001
2021-11-16 2021-09-30 13F IMMUNITYBIO INC COM Common Stock 45256X103 1,920 0 0.00 19 -29.63 0.0002
2021-08-16 2021-06-30 13F IMMUNITYBIO INC COM Common Stock 63016Q102 1,920 0 0.00 27 -41.30 0.0003
2021-05-17 2021-03-31 13F IMMUNITYBIO INC COM Common Stock 63016Q102 1,920 1,920 46 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.